Literature DB >> 12739764

Vitreous is a barrier in nonviral gene transfer by cationic lipids and polymers.

Leena Pitkänen1, Marika Ruponen, Jenni Nieminen, Arto Urtti.   

Abstract

PURPOSE: To investigate the role of vitreous in nonviral gene delivery into retinal pigment epithelial (RPE) cells.
METHODS: Human RPE cell line D407 was cultured in six-well plates. Bovine vitreous, hyaluronan, or DMEM was added on the cells. Complexes of DNA and cationic carriers (polyethyleneimine, poly-L-lysine, DOTAP liposomes) were pipetted onto the vitreous, hyaluronan, or DMEM. Cellular uptake of DNA was studied with ethidium monoazide DNA and gene expression with GFP-plasmid complexes. FITC-dextrans and FITC-polylysines were used to probe the effects of the size and cationic charge on permeation in the vitreous in a similar experimental setup. Fluorescent cells were analyzed by flow cytometry.
RESULTS: Vitreous decreased the cellular uptake of DNA complexes 2-30 times, and GFP expression was also impaired. In hyaluronan solutions the cellular uptake of the complexes was also decreased significantly in most cases. In vitreous, cellular uptake of all FITC-dextrans decreased slightly, and uptake of poly-L-lysines was decreased substantially, whereas in hyaluronan solutions the effects were mild or nonexistent.
CONCLUSIONS: Polymeric and liposomal gene delivery is substantially limited by the vitreous. This is probably because of the size and charge of the retinal gene delivery after intravitreal injections.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12739764     DOI: 10.1023/a:1023238530504

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  28 in total

1.  Novel cationic amphiphilic 1,4-dihydropyridine derivatives for DNA delivery.

Authors:  Z Hyvönen; A Plotniece; I Reine; B Chekavichus; G Duburs; A Urtti
Journal:  Biochim Biophys Acta       Date:  2000-12-20

Review 2.  Ocular gene therapy: quo vadis?

Authors:  W W Hauswirth; L Beaufrere
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-09       Impact factor: 4.799

3.  Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.

Authors:  H Miyoshi; M Takahashi; F H Gage; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

4.  Construction of plasmids that express E. coli beta-galactosidase in mammalian cells.

Authors:  G R MacGregor; C T Caskey
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

5.  Movement of horseradish peroxidase in the cornea, sclera and the anterior uvea.

Authors:  A M Tonjum
Journal:  Acta Ophthalmol (Copenh)       Date:  1977-10

6.  Experimental subretinal neovascularization is inhibited by adenovirus-mediated soluble VEGF/flt-1 receptor gene transfection: a role of VEGF and possible treatment for SRN in age-related macular degeneration.

Authors:  M Honda; T Sakamoto; T Ishibashi; H Inomata; H Ueno
Journal:  Gene Ther       Date:  2000-06       Impact factor: 5.250

7.  Use of a dicistronic expression cassette encoding the green fluorescent protein for the screening and selection of cells expressing inducible gene products.

Authors:  D D Mosser; A W Caron; L Bourget; P Jolicoeur; B Massie
Journal:  Biotechniques       Date:  1997-01       Impact factor: 1.993

8.  Gene delivery and expression in human retinal pigment epithelial cells: effects of synthetic carriers, serum, extracellular matrix and viral promoters.

Authors:  A Urtti; J Polansky; G M Lui; F C Szoka
Journal:  J Drug Target       Date:  2000       Impact factor: 5.121

9.  A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides.

Authors:  I Jääskeläinen; S Peltola; P Honkakoski; J Mönkkönen; A Urtti
Journal:  Eur J Pharm Sci       Date:  2000-05       Impact factor: 4.384

10.  Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies.

Authors:  M Ruponen; S Ylä-Herttuala; A Urtti
Journal:  Biochim Biophys Acta       Date:  1999-01-08
View more
  27 in total

Review 1.  Ocular drug delivery.

Authors:  Ripal Gaudana; Hari Krishna Ananthula; Ashwin Parenky; Ashim K Mitra
Journal:  AAPS J       Date:  2010-05-01       Impact factor: 4.009

2.  Can ultrasound solve the transport barrier of the neural retina?

Authors:  Liesbeth Peeters; Ine Lentacker; Roosmarijn E Vandenbroucke; Bart Lucas; Joseph Demeester; Niek N Sanders; Stefaan C De Smedt
Journal:  Pharm Res       Date:  2008-07-23       Impact factor: 4.200

3.  Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina.

Authors:  Hyuncheol Kim; Shaun B Robinson; Karl G Csaky
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

Review 4.  Small-interfering RNAs (siRNAs) as a promising tool for ocular therapy.

Authors:  A Guzman-Aranguez; P Loma; J Pintor
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

Review 5.  AAV and compacted DNA nanoparticles for the treatment of retinal disorders: challenges and future prospects.

Authors:  Zongchao Han; Shannon M Conley; Muna I Naash
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-10       Impact factor: 4.799

Review 6.  New techniques for drug delivery to the posterior eye segment.

Authors:  Esther Eljarrat-Binstock; Jacob Pe'er; Abraham J Domb
Journal:  Pharm Res       Date:  2010-02-13       Impact factor: 4.200

7.  In vitro and computational modelling of drug delivery across the outer blood-retinal barrier.

Authors:  Alys E Davies; Rachel L Williams; Gaia Lugano; Serban R Pop; Victoria R Kearns
Journal:  Interface Focus       Date:  2020-02-14       Impact factor: 3.906

8.  Neural retina limits the nonviral gene transfer to retinal pigment epithelium in an in vitro bovine eye model.

Authors:  Leena Pitkänen; Jukka Pelkonen; Marika Ruponen; Seppo Rönkkö; Arto Urtti
Journal:  AAPS J       Date:  2004-10-07       Impact factor: 4.009

9.  Non-viral siRNA delivery into the mouse retina in vivo.

Authors:  Andrey Turchinovich; Georg Zoidl; Rolf Dermietzel
Journal:  BMC Ophthalmol       Date:  2010-10-01       Impact factor: 2.209

10.  Oxidative stress protection by exogenous delivery of rhHsp70 chaperone to the retinal pigment epithelium (RPE), a possible therapeutic strategy against RPE degeneration.

Authors:  Astrid Subrizi; Elisa Toropainen; Eva Ramsay; Anu J Airaksinen; Kai Kaarniranta; Arto Urtti
Journal:  Pharm Res       Date:  2014-07-17       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.